155 related articles for article (PubMed ID: 38481285)
1. Apparent diffusion coefficient values predict response to brachytherapy in bulky cervical cancer.
Dong EE; Xu J; Kim JW; Bryan J; Appleton J; Hamstra DA; Ludwig MS; Hanania AN
Radiat Oncol; 2024 Mar; 19(1):35. PubMed ID: 38481285
[TBL] [Abstract][Full Text] [Related]
2. Apparent diffusion coefficients in GEC ESTRO target volumes for image guided adaptive brachytherapy of locally advanced cervical cancer.
Haack S; Pedersen EM; Jespersen SN; Kallehauge JF; Lindegaard JC; Tanderup K
Acta Oncol; 2010 Oct; 49(7):978-83. PubMed ID: 20831485
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation.
Ho JC; Allen PK; Bhosale PR; Rauch GM; Fuller CD; Mohamed AS; Frumovitz M; Jhingran A; Klopp AH
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):546-553. PubMed ID: 28011045
[TBL] [Abstract][Full Text] [Related]
4. Volumetric assessment of apparent diffusion coefficient predicts outcome following chemoradiation for cervical cancer.
Ho JC; Fang P; Cardenas CE; Mohamed ASR; Fuller CD; Allen PK; Bhosale PR; Frumovitz MM; Jhingran A; Klopp AH
Radiother Oncol; 2019 Jun; 135():58-64. PubMed ID: 31015171
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of quantitative diffusion-weighted imaging during intra-procedural MRI-guided brachytherapy of locally advanced cervical and vaginal cancers.
Jacobsen MC; Rigaud B; Simiele SJ; Rauch GM; Ning MS; Vedam S; Klopp AH; Stafford RJ; Brock KK; Venkatesan AM
Brachytherapy; 2023; 22(6):736-745. PubMed ID: 37612174
[TBL] [Abstract][Full Text] [Related]
6. A prospective study of DWI, DCE-MRI and FDG PET imaging for target delineation in brachytherapy for cervical cancer.
Han K; Croke J; Foltz W; Metser U; Xie J; Shek T; Driscoll B; Ménard C; Vines D; Coolens C; Simeonov A; Beiki-Ardakani A; Leung E; Levin W; Fyles A; Milosevic MF
Radiother Oncol; 2016 Sep; 120(3):519-525. PubMed ID: 27528120
[TBL] [Abstract][Full Text] [Related]
7. Comparison of computed tomography with magnetic resonance imaging for imaging-based clinical target volume contours in cervical cancer brachytherapy.
Zolciak-Siwinska A; Kowalczyk A; Sikorska K; Bijok M; Michalski W; Gruszczynska E
Brachytherapy; 2018; 17(4):667-672. PubMed ID: 29764769
[TBL] [Abstract][Full Text] [Related]
8. Dynamics of High Risk Clinical Target Volume reduction during Brachytherapy and impact on its coverage in patients with inoperable cervical cancer.
Pobijakova M; Scepanovic D; Paluga M; Fekete M; Mardiak J
Neoplasma; 2018 Mar; 65(3):425-430. PubMed ID: 29788726
[TBL] [Abstract][Full Text] [Related]
9. Combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging to predict neoadjuvant chemotherapy effect in FIGO stage IB2-IIA2 cervical cancers.
Zhang A; Song J; Ma Z; Chen T
Radiol Med; 2020 Dec; 125(12):1233-1242. PubMed ID: 32424659
[TBL] [Abstract][Full Text] [Related]
10. [Value of MR diffusion-weighted imaging in diagnosis and outcome prediction for uterine cervical cancer].
Wu B; Huang X; Peng W; Gu Y; Yang T; Mao J; Ke G; Wu X
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):115-9. PubMed ID: 24796459
[TBL] [Abstract][Full Text] [Related]
11. Use of Functional Magnetic Resonance Imaging in Cervical Cancer Patients With Incomplete Response on Positron Emission Tomography/Computed Tomography After Image-Based High-Dose-Rate Brachytherapy.
Kalash R; Glaser SM; Rangaswamy B; Horne ZD; Kim H; Houser C; Beriwal S
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1008-1013. PubMed ID: 29559287
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Computed Tomography- and Magnetic Resonance Imaging-based Clinical Target Volume Contours at Brachytherapy for Cervical Cancer.
Swanick CW; Castle KO; Vedam S; Munsell MF; Turner LM; Rauch GM; Jhingran A; Eifel PJ; Klopp AH
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):793-800. PubMed ID: 27788952
[TBL] [Abstract][Full Text] [Related]
13. Value of apparent diffusion coefficient (ADC) in assessing radiotherapy and chemotherapy success in cervical cancer.
Fu ZZ; Peng Y; Cao LY; Chen YS; Li K; Fu BH
Magn Reson Imaging; 2015 Jun; 33(5):516-24. PubMed ID: 25660642
[TBL] [Abstract][Full Text] [Related]
14. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
[TBL] [Abstract][Full Text] [Related]
15. Evaluation and evolution of apparent diffusion coefficient (ADC) in image-guided adaptive brachytherapy (IGABT) for cervical cancer.
Kumar R; Kala P; Narayanan GS; Vishwanathan B; Narayanan S; Mandal S; Rao A; Gowda G
Brachytherapy; 2021; 20(1):112-117. PubMed ID: 32928683
[TBL] [Abstract][Full Text] [Related]
16. A Prospective Comparison of Computed Tomography with Transrectal Ultrasonography Assistance and Magnetic Resonance Imaging-Based Target-Volume Definition During Image Guided Adaptive Brachytherapy for Cervical Cancers.
Mahantshetty U; Naga Ch P; Khadanga CR; Gudi S; Chopra S; Gurram L; Jamema S; Ghadi Y; Shrivastava S
Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1448-1456. PubMed ID: 30146092
[TBL] [Abstract][Full Text] [Related]
17. Tumor radiomic heterogeneity: Multiparametric functional imaging to characterize variability and predict response following cervical cancer radiation therapy.
Bowen SR; Yuh WTC; Hippe DS; Wu W; Partridge SC; Elias S; Jia G; Huang Z; Sandison GA; Nelson D; Knopp MV; Lo SS; Kinahan PE; Mayr NA
J Magn Reson Imaging; 2018 May; 47(5):1388-1396. PubMed ID: 29044908
[TBL] [Abstract][Full Text] [Related]
18. Pre-treatment diffusion-weighted MR imaging for predicting tumor recurrence in uterine cervical cancer treated with concurrent chemoradiation: value of histogram analysis of apparent diffusion coefficients.
Heo SH; Shin SS; Kim JW; Lim HS; Jeong YY; Kang WD; Kim SM; Kang HK
Korean J Radiol; 2013; 14(4):616-25. PubMed ID: 23901319
[TBL] [Abstract][Full Text] [Related]
19. Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy.
Liu ZS; Guo J; Zhao YZ; Lin X; Zhang BY; Zhang C; Wang HY; Yu L; Ren XJ; Wang TJ
Int J Gynecol Cancer; 2017 May; 27(4):768-775. PubMed ID: 28267131
[TBL] [Abstract][Full Text] [Related]
20. Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: a comparison of spatial dose distribution within a matched-pair analysis.
Schmid MP; Kirisits C; Nesvacil N; Dimopoulos JC; Berger D; Pötter R
Radiother Oncol; 2011 Sep; 100(3):468-72. PubMed ID: 21924510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
